tetano
Editor, Senior Moderator
Life Sci
. 2020 Jun 3;117905.
doi: 10.1016/j.lfs.2020.117905. Online ahead of print.
Protective Role of ACE2 and Its Downregulation in SARS-CoV-2 Infection Leading to Macrophage Activation Syndrome: Therapeutic Implications
Nehla Banu[SUP] 1 [/SUP], Sandeep Surendra Panikar[SUP] 2 [/SUP], Lizbeth Riera Leal[SUP] 3 [/SUP], Annie Riera Leal[SUP] 4 [/SUP]
Affiliations
Abstract
In light of the outbreak of the 2019 novel coronavirus disease (COVID-19), the international scientific community has joined forces to develop effective treatment strategies. The Angiotensin-Converting Enzyme (ACE) 2, is an essential receptor for cell fusion and engulfs the SARS coronavirus infections. ACE2 plays an important physiological role, practically in all the organs and systems. Also, ACE2 exerts protective functions in various models of pathologies with acute and chronic inflammation. While ACE2 downregulation by SARS-CoV-2 spike protein leads to an overactivation of Angiotensin (Ang) II/AT1R axis and the deleterious effects of Ang II may explain the multiorgan dysfunction seen in patients. Specifically, the role of Ang II leading to the appearance of Macrophage Activation Syndrome (MAS) and the cytokine storm in COVID-19 is discussed below. In this review, we summarized the latest research progress in the strategies of treatments that mainly focus on reducing the Ang II-induced deleterious effects rather than attenuating the virus replication.
Keywords: ACE2; COVID-19; Coronavirus; Macrophage Activation Syndrome (MAS); RAS system; SARS.
. 2020 Jun 3;117905.
doi: 10.1016/j.lfs.2020.117905. Online ahead of print.
Protective Role of ACE2 and Its Downregulation in SARS-CoV-2 Infection Leading to Macrophage Activation Syndrome: Therapeutic Implications
Nehla Banu[SUP] 1 [/SUP], Sandeep Surendra Panikar[SUP] 2 [/SUP], Lizbeth Riera Leal[SUP] 3 [/SUP], Annie Riera Leal[SUP] 4 [/SUP]
Affiliations
- PMID: 32504757
- DOI: 10.1016/j.lfs.2020.117905
Abstract
In light of the outbreak of the 2019 novel coronavirus disease (COVID-19), the international scientific community has joined forces to develop effective treatment strategies. The Angiotensin-Converting Enzyme (ACE) 2, is an essential receptor for cell fusion and engulfs the SARS coronavirus infections. ACE2 plays an important physiological role, practically in all the organs and systems. Also, ACE2 exerts protective functions in various models of pathologies with acute and chronic inflammation. While ACE2 downregulation by SARS-CoV-2 spike protein leads to an overactivation of Angiotensin (Ang) II/AT1R axis and the deleterious effects of Ang II may explain the multiorgan dysfunction seen in patients. Specifically, the role of Ang II leading to the appearance of Macrophage Activation Syndrome (MAS) and the cytokine storm in COVID-19 is discussed below. In this review, we summarized the latest research progress in the strategies of treatments that mainly focus on reducing the Ang II-induced deleterious effects rather than attenuating the virus replication.
Keywords: ACE2; COVID-19; Coronavirus; Macrophage Activation Syndrome (MAS); RAS system; SARS.